These small percentages are in reasonable agreement with those found in the COSMIC database [109] and seem to suggest that, although NSD2 mutations can be involved in the tumor progression in many different types of hematopoietic malignancies, its most relevant pathological role is played in the context of B-ALL, MM, and MCL. The gene discussed is NSD2; the disease is mantle cell lymphoma.